Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Mairs

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nuclear Medicine Communications|April 1, 1994
Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidineR J Mairs, M N Gaze, D G Watson, et al.
Oncogene|December 26, 2001
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell killM Boyd, R J Mairs, S C Mairs, et al.
Gene Therapy|September 29, 2006
p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapyH O McCarthy, J Worthington, E Barrett, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1984
The effect of cytotoxic therapy on saliva and oral floraB E Main, K C Calman, M M Ferguson, et al.
The Journal of Gene Medicine|April 25, 2001
A gene therapy/targeted radiotherapy strategy for radiation cell kill byM Boyd, R J Mairs, S H Cunningham, et al.
British Journal of Cancer|January 19, 2000
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat modelR J Mairs, C L Wideman, W J Angerson, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nuclear Medicine Communications|April 1, 1994
Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidineR J Mairs, M N Gaze, D G Watson, et al.
Oncogene|December 26, 2001
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell killM Boyd, R J Mairs, S C Mairs, et al.
Gene Therapy|September 29, 2006
p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapyH O McCarthy, J Worthington, E Barrett, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|November 1, 1984
The effect of cytotoxic therapy on saliva and oral floraB E Main, K C Calman, M M Ferguson, et al.
The Journal of Gene Medicine|April 25, 2001
A gene therapy/targeted radiotherapy strategy for radiation cell kill byM Boyd, R J Mairs, S H Cunningham, et al.
British Journal of Cancer|January 19, 2000
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat modelR J Mairs, C L Wideman, W J Angerson, et al.
Pageof 5